China's Jiuyuan Genetic seeks approval for Wegovy biosimilar
China's Jiuyuan Genetic seeks approval for Wegovy biosimilar is drawing significant interest across the industry.
Jiuyuan Genetic Biopharmaceutical has applied for approval to sell its experimental biosimilar version of Novo Nordisk's NOVOb.CO blockbuster weight-loss drug Wegovy in China, the Chinese drugmaker said Wednesday.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Michigan basketball clinches Big Ten Tournament triple-bye ahead of ‘Duel in the District’ game vs. Duke
- Empowering Youth: American Express & Magic Bus India Foundation's Skills Initiative
- ClearProfit Launches Profit Tracking App Designed for Shopify Merchants
- Threads is testing a shortcut to quickly start DM conversations
Source: Original →